The analysis of limited-quantity samples remains a challenge associated with mouse models, especially for multi-platform metabolomics studies. Although inherently insensitive, the highly specific characteristics of nuclear magnetic resonance (NMR) spectroscopy make it an advantageous platform for global metabolite profiling, particularly in mitochondrial disease research.
Show method equivalency between a well-established standard operating protocol (SOP) and our novel miniaturized 1H-NMR method.
The miniaturized method was performed in a 2 mm NMR tube on a standard 500 MHz NMR spectrometer with a 5 mm triple-resonance inverse TXI probe at room temperature.
Firstly, using synthetic urine spiked with low (50 µM), medium (250 µM) and high (500 µM) levels (n = 10) of nine standards, both the SOP and miniaturized method were shown to have acceptable precision (CV < 15%), relative accuracy (80–120%), and linearity (R2 > 0.95), except for taurine. Furthermore, statistical equivalence was shown using the two one-sided test. Secondly, pooled mouse quadriceps muscle extract was used to further confirm method equivalence (n = 3), as well as explore the analytical dynamics of this novel approach by analyzing more-concentrated versions of samples (up to 10× concentration) to expand identification of metabolites qualitatively, with quantitative linearity. Lastly, we demonstrate the new technique’s application in a pilot metabolomics study using minute soleus muscle tissue from a mouse model of Leigh syndrome using Ndufs4 KO mice.
We demonstrate method equivalency, supporting our novel miniaturized 1H-NMR method as a financially feasible alternative to cryoprobe technology—for limited-quantity biological samples in metabolomics studies that requires a volume one-tenth of the SOP.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Beckonert, O., Keun, H. C., Ebbels, T. M. D., Bundy, J., Holmes, E., Lindon, J. C., et al. (2007). Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nature Protocols, 2, 2692–2703.
Cassiède, M., Nair, S., Dueck, M., Mino, J., McKay, R., Mercier, P., et al. (2017). Assessment of 1H NMR-based metabolomics analysis for normalization of urinary metals against creatinine. Clinica Chimica Acta, 464, 37–43.
Chambers, D., Kelly, G., Limentani, G., Lister, A., Lung, K. R., & Warner, E. (2005). Analytical method equivalency. Pharmaceutical Technology, 29, 64–80.
Chan, C. C., Lee, Y. C., Lam, H., & Zhang, X. M. (Eds.). (2004). Analytical method validation and instrument performance verification. Hoboken: Wiley.
Dona, A. C., Jiménez, B., Schäfer, H., Humpfer, E., Spraul, M., Lewis, M. R., et al. (2014). Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Analytical Chemistry, 86, 9887–9894.
Dunn, W. B., Wilson, I. D., Nicholls, A. W., & Broadhurst, D. (2012). The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis, 4, 2249–2264.
Esterhuizen, K., van der Westhuizen, F. H., & Louw, R. (2017). Metabolomics of mitochondrial disease. Mitochondrion, 35, 97–110.
Figueira, J., Jonsson, P., Adolfsson, A. N., Adolfsson, R., Nyberg, L., & Öhman, A. (2016). NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls. Molecular BioSystems, 12, 2562–2571.
Fratila, R. M., & Velders, A. H. (2011). Small-volume nuclear magnetic resonance spectroscopy. Annual Review of Analytical Chemistry, 4, 227–249.
Glaves, J. P., Li, M. X., Mercier, P., Fahlman, R. P., & Sykes, B. D. (2014). High-throughput, multi-platform metabolomics on very small volumes: 1H NMR metabolite identification in an unadulterated tube-in-tube system. Metabolomics, 10, 1145–1151.
Gullberg, J., Jonsson, P., Nordström, A., Sjöström, M., & Moritz, T. (2004). Design of experiments: An efficient strategy to identify factors influencing extraction and derivatization of Arabidopsis thaliana samples in metabolomic studies with gas chromatography/mass spectrometry. Analytical Biochemistry, 331, 283–295.
Hohmann, M., Felbinger, C., Christoph, N., Wachter, H., Wiest, J., & Holzgrabe, U. (2014). Quantification of taurine in energy drinks using 1 H NMR. Journal of Pharmaceutical and Biomedical Analysis, 93, 156–160.
Johansson, T., Jurva, U., Grönberg, G., Weidolf, L., & Masimirembwa, C. (2009). Novel metabolites of amodiaquine formed by CYP1A1 and CYP1B1: Structure elucidation using electrochemistry, mass spectrometry, and NMR. Drug Metabolism and Disposition, 37, 571–579.
Kayser, E., Sedensky, M. M., & Morgan, P. G. (2016). Region-specific defects of respiratory capacities in the Ndufs4(KO) mouse brain. PLoS ONE, 11, 1–18.
Koves, T. R., Noland, R. C., Bates, A. L., Henes, S. T., Muoio, D. M., & Cortright, R. N. (2005). Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism. American Journal of Physiology-Cell Physiology, 288, C1074–C1082.
Li, H., Kumar Sharma, L., Li, Y., Hu, P., Idowu, A., Liu, D., et al. (2013). Comparative bioenergetic study of neuronal and muscle mitochondria during aging. Free Radical Biology and Medicine, 63, 30–40.
Limentani, G. B., Ringo, M. C., Ye, F., Bergquist, M. L., & McSorley, E. O. (2005). Beyond the t-test: Statistical equivalence testing. Analytical Chemistry, 77, 221A–226A.
Lindon, J. C., Holmes, E., Bollard, M. E., Stanley, E. G., & Nicholson, J. K. (2004). Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers, 9, 1–31.
Madji Hounoum, B., Mavel, S., Coque, E., Patin, F., Vourc’h, P., Marouillat, S., et al. (2017). Wildtype motoneurons, ALS-Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling. Glia, 65, 592–605.
Martin, G. E. (2005). Small-volume and high-sensitivity NMR probes. Annual Reports on NMR Spectroscopy, 56, 1–96.
Schmitt-Kopplin, P., Harir, M., Kanawati, B., Tziozis, D., Hertkorn, N., & Gabelica, Z. (2012b). Chemical footprint of the solvent soluble extraterrestrial organic matter occluded in Sołtmany ordinary chondrite. Meteorites, 2, 79–92.
Schmitt-Kopplin, P., Liger-Belair, G., Koch, B. P., Flerus, R., Kattner, G., Harir, M., Kanawati, B., Lucio, M., Tziotis, D., Hertkorn, N., & Gebefügi, I. (2012a). Dissolved organic matter in sea spray: A transfer study from marine surface water to aerosols. Biogeosciences, 9, 1571–1582.
US FDA. Guidance for industry, bioanalytical method validation. US FDA, MD, USA (2001).
Xia, J., Sinelnikov, I., Han, B., & Wishart, D. S. (2015). MetaboAnalyst 3.0—making metabolomics more meaningful. Nucleic Acids Research, 43, W251–W257.
This work is based on the research supported by the National Research Foundation of South Africa (Grant No. 92736) and the Technological Innovation Agency of the Department of Science and Technology of South Africa.
Conflict of interest
All authors declare that they have no conflict of interest.
The AnimCare animal research ethics committee of North-West University approved (NWU-00378-16-A5) the animal protocols used here. All animals were maintained and all procedures performed in accordance with the code of ethics in research, training and testing of drugs in South Africa and complied with national legislation.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Mason, S., Terburgh, K. & Louw, R. Miniaturized 1H-NMR method for analyzing limited-quantity samples applied to a mouse model of Leigh disease. Metabolomics 14, 74 (2018). https://doi.org/10.1007/s11306-018-1372-6
- Nuclear magnetic resonance (NMR) spectroscopy
- Ndufs4 KO mice, Leigh disease
- Mouse model studies